Related Experiment Videos

Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia

J B Rubins1, C Pomeroy

  • 1Veterans Affairs Medical Center, and Department of Medicine, University of Minnesota, Minneapolis 55417, USA. rubin004@maroon.tc.umn.edu

Infection and Immunity
|July 1, 1997
PubMed

Insights

Gamma interferon (IFN-gamma) levels increase in mice with virulent pneumococcal infections, indicating a protective role. This immune response is crucial for combating pneumococcal disease.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Pneumococcal infections pose significant public health challenges.
  • The role of specific immune mediators like gamma interferon (IFN-gamma) in host defense against pneumococci requires further elucidation.

Purpose of the Study:

  • To investigate the role of gamma interferon (IFN-gamma) in the host response to pulmonary infection with virulent and avirulent Streptococcus pneumoniae strains in a murine model.

Main Methods:

  • Murine model of pulmonary pneumococcal infection.
  • Measurement of serum and lung gamma interferon (IFN-gamma) concentrations.
  • Comparison of mortality rates between wild-type and IFN-gamma gene knockout mice.

Main Results:

  • Virulent pneumococcal infection led to a significant increase in serum IFN-gamma concentrations at 24–48 hours post-infection.
  • Avirulent strains induced only minimal increases in serum IFN-gamma.
  • IFN-gamma gene knockout mice exhibited increased mortality following pulmonary infection compared to immunocompetent mice.

Conclusions:

  • Gamma interferon (IFN-gamma) plays a critical protective role in the host response to virulent pneumococcal pulmonary infections.
  • Elevated IFN-gamma levels are a key indicator of the host's immune response to severe pneumococcal disease.

Related Concept Videos